Thank you, Mark. As many of you are aware, earlier this year, we successfully retenanted our Beaumont, Texas facility with CHRISTUS Health as our new tenant. I'm pleased to announce that as of May, CHRISTUS is fully operating in the facility and is paying rent. This is a huge success story given the status of the previous tenant, Steward Health Care, and an example of our team's ability to navigate obstacles to a successful conclusion. More broadly on the portfolio. As of June 30, 2025, our occupancy stood at 94.5%, which is down from the first quarter, primarily due to the expiration of the lease at our 50,000 square foot Aurora, Illinois property and the rejection of the master lease at our 60,000 square foot East Orange, New Jersey property related to the Prospect Medical bankruptcy. We touched on both of these in prior calls, but I'd like to offer a little more color. In Aurora, this was a health care administrative building adjacent to one of the system's new outpatient facilities. We purchased this building pre-COVID with an expectation that the system would expand and unfortunately, COVID changed the system's utilization of the administrative space. We are currently looking to sell or retenant this facility. On the flip side, after almost 2 years of negative cash flows, the developments at East Orange are positive. We now have control over the space, which is 40% occupied and are working directly with former subtenants and prospective tenants, including the new adjacent hospital operator. We expect this property to recover to stabilized occupancy of over 90% in the next 24 to 36 months. Turning to our leasing activity. We expect total occupancy to end the year over 95%, which includes 150,000 square feet of new leases, 130,000 of which are complete. Regarding CapEx and leasing commissions, year-to-date spend is $5.2 million, and our guidance for the full year is between $12 million to $14 million. So we are well positioned. I would now like to turn the call over to Alfonzo to discuss our investments. Alfonzo?